Transcriptomics

Dataset Information

0

Non-canonical immune response to inhibition of DNA methylation via stabilization of dsRNAs from endogenous retroviruses


ABSTRACT: 5-Aza-2'-deoxycytidine, also known as decitabine, is a DNA hypomethylating agent (HMA) used to treat acute myeloid leukemia (AML) and pre-leukemic disorder myelodysplastic syndrome (MDS). Decitabine activates the transcription of endogenous retroviruses (ERV), which can induce immune response by acting as cellular double-stranded RNAs. Here, we employ an image-based screening system to identify dsRNA-binding factors that mediate the downstream effect of ERV induction. We find that STAUFEN1 (STAU1) knockdown decreases the interferon signature and rescues decitabine-mediated cell death. Our subsequent analyses reveal that STAU1 directly binds to ERV RNAs and stabilizes the RNAs together with a long noncoding RNA, TINCR. Analysis of a clinical patient cohort further supports that MDS and AML patients with low STAU1 and TINCR expressions exhibited poor response to the HMA therapy. Our study reveals that decitabine-mediated cell death is a consequence of complex interactions among different dsRNA binding proteins for access to their common dsRNA targets.

ORGANISM(S): Homo sapiens

PROVIDER: GSE152258 | GEO | 2021/04/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2012-10-10 | E-GEOD-40121 | biostudies-arrayexpress
2012-10-10 | E-GEOD-40122 | biostudies-arrayexpress
2012-10-10 | GSE40122 | GEO
2012-10-10 | GSE40121 | GEO
2024-07-25 | PXD050539 | Pride
2022-06-01 | GSE165187 | GEO
2022-06-01 | GSE165185 | GEO
2018-02-23 | GSE79375 | GEO
2016-04-30 | GSE80762 | GEO
2024-07-24 | GSE261338 | GEO